Indirect Comparison Between Eltrombopag & Romiplostim

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Thrombocytopaenia

Treatments: Drug: Romiplostim; Drug: Placebo; Drug: Eltrombopag

Study type: Observational

Funder types: Industry

Identifiers

NCT01236014

114014

Details and patient eligibility

About

An indirect comparison to compare the efficacy of eltrombopag versus romiplostim

Full description

An indirect analysis was conducted to evaluate the relative efficacy of eltrombopag and romiplostim using placebo as a common comparator

Enrollment: 1 patient

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults with ITP
• Pre-specified treatment
• Prospective clinical studies with at least 10 patients

Exclusion criteria

• Adults with ITP for other reasons

Trial design

1 participants in 3 patient groups

Eltrombopag & standard of care

Treatment:

Drug: Eltrombopag

Romiplostim & standard of care

Treatment:

Drug: Romiplostim

Standard of care

Treatment:

Drug: Placebo